한글목차

세계의 스텐트 시장은 2024년에 150억 4,000만 달러로 평가되며, 2030년에는 347억 5,000만 달러에 달하며, CAGR 4.38%로 성장할 것으로 예측됩니다.

스텐트는 좁아지거나 약해진 동맥을 보강하기 위해 사용되는 작은 메쉬 튜브로 관상동맥질환, 말초동맥질환 등 심혈관질환 관리에 중요한 역할을 하고 있습니다. 당뇨병, 고혈압, 비만 등 동맥폐색 위험을 높이는 생활습관 관련 건강상태의 유병률이 증가함에 따라 시장이 확대되고 있습니다. 전 세계에서 노인 인구가 증가하고 앉아서 생활하는 생활방식으로 변화함에 따라 스텐트 삽입술에 대한 수요는 지속적으로 증가하고 있습니다. 이러한 급격한 증가는 인구 고령화가 진행되고 있는 선진국과 급속한 도시화와 헬스케어의 진화를 경험하고 있는 시장에서도 두드러지게 나타나고 있습니다. 그러나 이 시장은 특히 자원이 한정된 환경에서 첨단 스텐트 기술의 높은 비용과 복잡한 규제로 인해 새로운 혁신의 채택이 지연될 수 있는 장애물에 직면해 있습니다.

시장 성장 촉진요인

헬스케어 산업의 성장

주요 시장 과제

스텐트 접근 제한

주요 시장 동향

3D 프린팅 스텐트 개발 확대

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 COVID-19가 세계의 스텐트 시장에 미치는 영향

제5장 세계의 스텐트 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 제품 유형별(약제용출 스텐트, 베어메탈 관상동맥 스텐트, 생체흡수성 스텐트, 기타)
  • 최종 용도별(병원 클리닉, 외래 수술 센터, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 스텐트 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 스텐트 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 스텐트 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 스텐트 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동·아프리카의 스텐트 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병과 인수
• 제품 출시

제13장 혼란 : 분쟁, 팬데믹, 무역장벽

제14장 세계의 스텐트 시장 : SWOT 분석

제15장 Porter's Five Forces 분석

• 산업내의 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제16장 경쟁 구도

• Medtronic plc
• B. Braun Melsungen AG
• Terumo Corporation
• STENTYS SA
• MicroPort Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Translumina GmbH
• Biosensors International Group Limited
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG

제17장 전략적 제안

제18장 조사회사 소개·면책사항

영문목차

The Global Stent Market was valued at USD 15.04 Billion in 2024 and is projected to reach USD 34.75 Billion by 2030, growing at a CAGR of 4.38%. Stents are small mesh tubes used to reinforce narrowed or weakened arteries, playing a critical role in managing cardiovascular and vascular conditions such as coronary artery disease and peripheral artery disease. The market is expanding due to the increasing prevalence of lifestyle-related health conditions-such as diabetes, hypertension, and obesity-that heighten the risk of arterial blockages. With a rising geriatric population and the global shift toward sedentary lifestyles, the demand for stenting procedures continues to grow. This surge is evident in both developed countries with aging demographics and emerging markets experiencing rapid urbanization and healthcare evolution. However, the market faces hurdles including the high cost of advanced stent technologies, especially in resource-limited settings, and regulatory complexities that may slow the adoption of newer innovations.

Key Market Drivers

Growth in Healthcare Industry

The expansion of the global healthcare sector, which generates over USD 4 trillion annually, is significantly influencing the growth of the stent market. Key segments such as pharmaceuticals, biotechnology, medical technology, and diagnostics contribute hundreds of billions in revenue and are central to the rising demand for advanced treatment solutions. As investments in healthcare infrastructure increase worldwide, so does access to cutting-edge cardiovascular care. Public and private healthcare spending has enabled better-equipped hospitals, improved interventional cardiology services, and wider availability of diagnostic tools. Cardiovascular diseases, responsible for around 17.9 million deaths globally each year, remain the leading cause of mortality. Over 80% of these are due to heart attacks and strokes, with nearly one-third of cases occurring prematurely in people under 70. Stents are a standard component in the treatment of these conditions, particularly in angioplasty procedures. The adoption of advanced technologies and minimally invasive interventions has contributed to the widespread use of stents in both high-income and developing nations.

Key Market Challenges

Limited Accessibility of Stents

Limited accessibility to stents poses a significant challenge, particularly in low- and middle-income regions. Although technological advancements have made stent procedures more effective and less invasive, access remains uneven. Many patients in under-resourced areas encounter financial and infrastructural barriers that prevent them from receiving timely and effective treatment. A primary constraint is the high cost associated with advanced stents, including drug-eluting and bioabsorbable variants, which often exceed the budget of public healthcare systems in these regions. Costs extend beyond the devices themselves to include diagnostics, surgery, hospitalization, and post-operative care. In countries where insurance coverage is limited and public subsidies are scarce, patients are frequently left with few options-either forgoing treatment or settling for outdated or substandard alternatives.

Key Market Trends

Growing Development of 3D-Printed Stents

The development of 3D-printed stents marks a significant innovation in the stent market, driven by the need for personalized treatment and advancements in additive manufacturing. Unlike traditional stents, which come in standardized forms, 3D printing allows for custom-designed stents tailored to a patient's exact anatomical structure. This customization leads to improved placement accuracy, better clinical outcomes, and fewer complications such as restenosis or stent malapposition. A notable example includes patient-specific stents created at the Cleveland Clinic using CT imaging and proprietary 3D visualization software, where 3D-printed molds are used to shape medical-grade silicone. These personalized devices ensure a precise fit and highlight the potential of 3D printing to revolutionize cardiovascular care.

Key Market Players

• Medtronic plc
• B. Braun Melsungen AG
• Terumo Corporation
• STENTYS SA
• MicroPort Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Translumina GmbH
• Biosensors International Group Limited
• Boston Scientific Corporation
• BIOTRONIK SE & Co. KG

Report Scope

In this report, the Global Stent Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stent Market, By Product Type:

• Drug-Eluting Stent
• Bare Metal Coronary Stent
• Bioabsorbable Stent
• Others

Stent Market, By End Use:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Stent Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Stent Market.

Available Customizations

Global Stent Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Stent Market

5. Global Stent Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, Bioabsorbable Stent, Others)
  • 5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Stent Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Stent Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Stent Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Stent Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End Use

7. Europe Stent Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Stent Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Stent Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Stent Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Stent Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Stent Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End Use

8. Asia Pacific Stent Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Stent Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Stent Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Stent Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Stent Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Stent Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End Use

9. South America Stent Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Stent Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Stent Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Stent Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Stent Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Stent Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Stent Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Stent Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Stent Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Medtronic plc
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. B. Braun Melsungen AG
• 16.3. Terumo Corporation
• 16.4. STENTYS SA
• 16.5. MicroPort Scientific Corporation
• 16.6. Meril Life Sciences Pvt. Ltd
• 16.7. Translumina GmbH
• 16.8. Biosensors International Group Limited
• 16.9. Boston Scientific Corporation
• 16.10. BIOTRONIK SE & Co. KG

17. Strategic Recommendations

18. About Us & Disclaimer